Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
MIG Capital is a prominent venture capital firm located in Munich, Germany, founded in 2004. With a strong commitment to fostering innovation, MIG Capital primarily invests in early-stage companies within Europe, focusing on the sectors of Life Sciences and Deep Tech. The firm is distinguished as the only retail venture capital investor in Germany, offering publicly accessible funds that are supported by private investors. With a total capital commitment of €1.3 billion across 18 funds, MIG Capital has established a significant presence in the European venture capital landscape.
The firm has a reputation for its strategic investments, particularly in seed-stage companies, with typical check sizes ranging from €1 million to €10 million, often averaging around €3 million to €5 million. This investment strategy allows MIG Capital to support startups with substantial growth potential, particularly in innovative fields that are poised for disruption. Over the years, MIG Capital has built a diverse portfolio of 30 active companies, including notable successes and unicorns, reflecting its effective investment approach and deep understanding of market trends.
MIG Capital's investment focus is centered on sectors that are at the forefront of technological advancement and healthcare innovation. The firm actively invests in Deep Tech, which includes areas such as Advanced Computing, Digitalization & IoT, Energy & Environment, and New Materials. In the Life Sciences sector, MIG Capital emphasizes investments in Bio-pharmaceuticals, Therapeutics, Medical Technology, and Digital Health. This strategic focus enables the firm to identify and nurture startups that are developing groundbreaking solutions to pressing global challenges.
By concentrating on seed-stage investments, MIG Capital seeks to partner with visionary founders who are passionate about their ideas and possess the drive to bring them to fruition. The firm looks for companies that demonstrate significant growth potential and innovative approaches to their respective markets. With a keen eye for emerging trends and technologies, MIG Capital is well-positioned to support the next generation of industry leaders in both the Life Sciences and Deep Tech sectors.
MIG Capital boasts a diverse and dynamic portfolio, currently comprising 30 active companies across various sectors. Among its notable investments are Inbolt, which successfully raised €15 million in Series A funding for its AI-driven 3D vision technology in robotics, and SciRhom, an autoimmune biotech company that secured €63 million in Series A funding. The firm has achieved an impressive track record with 25 (partial) exits and 4 IPOs, showcasing its ability to identify and nurture high-potential startups.
Additionally, MIG Capital is proud to have two unicorns within its portfolio, highlighting its success in backing companies that have reached significant valuations. The firm's strategic investments in innovative companies reflect its commitment to fostering growth and supporting the development of transformative technologies in the Life Sciences and Deep Tech sectors.
To pitch MIG Capital, founders should prepare a detailed presentation that outlines their business model and growth strategy. While specific submission guidelines are not provided, a well-structured pitch is essential for consideration. It is advisable to reach out through their official website for any specific instructions or to inquire about the pitch process.
MIG Capital primarily invests in seed-stage companies. This focus allows the firm to support early-stage startups that demonstrate significant growth potential and innovative ideas.
Founders interested in pitching to MIG Capital should prepare a comprehensive presentation that outlines their business model, market opportunity, and growth strategy. While specific submission guidelines are not provided, a well-structured pitch is essential for consideration.
MIG Capital focuses on sectors including Life Sciences and Deep Tech. Within these areas, the firm invests in Bio-pharmaceuticals, Therapeutics, Medical Technology, Digital Health, Advanced Computing, Digitalization & IoT, Energy & Environment, and New Materials.
The typical check size for MIG Capital ranges from €1 million to €10 million, with an average investment of around €3 million to €5 million. This allows the firm to provide substantial support to early-stage companies.
MIG Capital primarily invests in Europe, focusing on innovative startups that are developing solutions in the Life Sciences and Deep Tech sectors.
MIG Capital is committed to supporting its portfolio companies through strategic guidance, access to its extensive network, and resources that facilitate growth and innovation. The firm actively engages with its startups to help them navigate challenges and seize opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.